• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Vape Recovery Goes Up in Smoke Amid Pandemic

Following widely reported lung injuries and bans, the products struggle to come back as concerns over Covid-19 burn on.
By DEBRA BORCHARDT
Sep 11, 2020 | 02:30 PM EDT
Stocks quotes in this article: TLLTF, CCORF, PM

Covid-19 could cause vape sales to hit the brakes on the product's road to recovery following last year's health crisis.

Doesn't it seem like a more innocent time, when the cannabis industry was worrying about e-cigarette vaping lung injury? Illicit makers of vape cartridges had been cutting vitamin E acetate into the cannabis oil with the tragic side effect that some consumers died.

By February, 2,807 people had been hospitalized for the lung injuries and 68 people died. A result was that an emerging powerhouse of a cannabis category, vaping, was plunged into the abyss of uncertainty. However, as more was learned and it seemed the illicit manufacturers were to blame, vape consumers began to return. Paying for an original, tested brand was a small price to pay to avoid a trip to the hospital.

Now, just as the vape market was beginning to make a comeback, a new study from the Stanford School of Medicine found that vaping was linked to substantially increased risk of Covid-19 in teens and young adults.

"Among young people who were tested for the virus that causes Covid-19, the research found that those who vaped were five to seven times more likely to be infected than those who did not use e-cigarettes," found the report.

So, what does this mean for cannabis companies who were ready to put the lung injury fiasco behind them and welcome back their vape customers?

A new survey by California-based online shopping company Ganja Goddess took a poll of more than 850 cannabis consumers and found a slight decline in the use of vape pens. The company said, "Prior to the start of the pandemic, 61% of consumers selected flower as the primary way they consumed cannabis; 50% selected edibles, 42% vapes pens and 12% tinctures. During the ongoing pandemic, when asked the same question, flower came in at 56% and vape pens at 36%, a 5% and 7% drop, respectively, which supports the notion that consumers are using edibles slightly more often than they did prior to the pandemic. Edibles saw a 1% increase at 51%, while tincture saw a 2% increase at 14% and pills/capsules saw a 3% increase coming in at 13%."

What's Hot in Pot?

According to new data from Curaleaf via Brightfield Group, the fastest-growing product types across categories from March 20-July 29 included:

Capsules & Tablets are up 304.8%

"Other Medicinals" are up 26%

Flower is up 16.4%

Tinctures are up 14.8%

Edibles are up 8.5%

Vapes were not mentioned as a growth category.

Sales Fade

This was further supported by Canaccord Genuity (CCORF) analyst Bobby Burleson who wrote about July cannabis sales in a new report on the industry. He reviewed sales data from Arizona, California, Colorado, Nevada and Oregon. Burleson said, "By product category, flower remained the largest percentage of retail sales in July at 45%, up from 38% in July 2019. Flower sales increased 57% Y/Y in July. After flower, non-vape concentrates (+56%) and pre rolls (+38%) experienced the highest sales growth over July 2019 levels. Vape was the only category to lose share. As a percentage of sales, vape declined from 25% in July 2019 to 19% this past July."

TILT Holdings   (TLLTF) , which owns the vape company Jupiter, also reported that its accessory category, which includes the Jupiter sales, declined slightly for the second quarter ending in June. The accessory category for TILT in the 2019 quarter were $31 million, which dipped slightly to $28 million in 2020. While $28 million is a respectable number, to see it dip by $3 million means the consumers are choosing something else.

The bottom line: With some states, like California, and cities, like Chicago, banning flavored tobacco vaping products, the stigma around vaping is not letting up. Plus, new hardware devices similar to Philip Morris' (PM)  IQOS, which heats dry material in a device that looks like a vape pen, could potentially disrupt the cannabis vape market in the future. IQOS is not in the cannabis industry, but copycat products are being created. Cannabis consumers could enjoy their flower without the worry of the vape oil. The question will be whether the recovery from the lung injury saga, can bounce back once again following the pandemic. Or, will consumers stick with new form factors now that they've tried them.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Borchardt did not own any securities mentioned.

TAGS: Investing | Stocks | Tobacco | Cannabis | Coronavirus

More from Stocks

Traders: Keep Your Fingers on the Trigger and Targets on a Bottom

James "Rev Shark" DePorre
Mar 4, 2021 4:39 PM EST

As the correction goes on, here's what to do now.

There's Nothing Pleasant About the Current Action

Timothy Collins
Mar 4, 2021 3:00 PM EST

The next good sized bounce in SPAC names, and maybe ARKK names, might be the last exit off the bagholder highway.

Nike's Charts and Indicators Are Still Bearish

Bruce Kamich
Mar 4, 2021 2:20 PM EST

Avoid the long side.

Listen to Mr. Market, Not Mr. Powell

Jim Collins
Mar 4, 2021 1:56 PM EST

Let's look at bonds, rates and, especially, inflation for a true picture of what's going on, and where to put your money.

Powell Supplies the Bears With Ammunition

James "Rev Shark" DePorre
Mar 4, 2021 1:20 PM EST

Picking good stocks is not going to help you much in this market right now.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:53 AM EST GARY BERMAN

    Nasdaq Composite: Some Backing and Filling Is Here

    As today is the 4th day of the month, it seems lik...
  • 07:59 AM EST PAUL PRICE

    Fabulous News on United Natural Foods (UNFI)

    The major potential risk factor for , its contrac...
  • 08:50 AM EST PAUL PRICE

    Michaels: Close to a Deal?

    It appears that a deal could be announced soon. ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login